The following section summarizes insights on International School Augsburg -ISA- gemeinnützige AG's Total Debt:
Nektar Therapeutics's latest twelve months current ratio is 2.6x
Nektar Therapeutics's current ratio for fiscal years ending December 2020 to 2024 averaged 7.6x.
Nektar Therapeutics's operated at median current ratio of 8.0x from fiscal years ending December 2020 to 2024.
Looking back at the last 5 years, Nektar Therapeutics's current ratio peaked in December 2020 at 9.8x.
Nektar Therapeutics's current ratio hit its 5-year low in December 2024 of 4.3x.
Nektar Therapeutics's current ratio decreased in 2021 (9.3x, -5.0%), 2022 (8.0x, -14.3%), 2023 (6.5x, -19.4%), and 2024 (4.3x, -34.0%) and increased in 2020 (9.8x, +144.7%).
Press space bar to start a drag.
When dragging you can use the arrow keys to move the item around and escape to cancel.
Some screen readers may require you to be in focus mode or to use your pass through key